Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib

• Dylan Graetz,
• Kristine R. Crews,
• Elizabeth M. Azzato,
• Ravi K. Singh,
• Susana Raimondi,
• John Mason,
• Marcus Valentine,
• Charles G. Mullighan,
• Ashley Holland,
• Hiroto Inaba,
• Vasiliki Leventaki

Affiliations

Dylan Graetz

Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN

Kristine R. Crews

Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN

Elizabeth M. Azzato

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

Ravi K. Singh

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

Susana Raimondi

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

John Mason

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

Marcus Valentine

Department of Cytogenetics, St. Jude Children’s Research Hospital, Memphis, TN

Charles G. Mullighan

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN

Ashley Holland

Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN

Hiroto Inaba

Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN

Vasiliki Leventaki

Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN;Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA